Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Jamoulle

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal De Pharmacie De Belgique|May 1, 1974
[The synthesis of 3-thiolpyridine 2-sulfonic acid]J C Jamoulle
Annales De Dermatologie Et De Venereologie|January 1, 1988
[Cutaneous penetration]J C Jamoulle
International Journal of Dermatology|July 1, 1988
Skin pharmacokineticsH Schaefer, J C Jamoulle
Journal De Pharmacie De Belgique|March 1, 1975
[Synthesis of some 2-alkylsulfonyl pyridines substituted at the 3-position]J C Jamoulle, C L Lapière
Journal De Pharmacie De Belgique|November 1, 1977
[Synthesis and antimitotic activity of nitro(pyrimidine-2-yl)2-thiopyridines (author's transl)]J C Jamoulle, C L Lapière
Annales Pharmaceutiques Francaises|January 1, 1983
[Anti-ulcerogenic derivatives in the thiocarbonylthiazolidine series: 3-pyridylthiocarbonyl[3,2-d]pyridothiazolidines]J C Jamoulle, C L Lapière
Biochemistry|January 27, 1987
Respective role of each of the purine N7 nitrogens of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine in binding to and activation of the RNase L of mouse cellsJ C Jamoulle, K Lesiak, P F Torrence
Annales Pharmaceutiques Francaises|January 1, 1979
[Synthesis of new potentially antimitotic heterocyclic thioethers (author's transl)]J C Jamoulle, C L Lapiere, J Bourdais
Annales Pharmaceutiques Francaises|January 1, 1985
[Radiosensitizing properties of an analog of azathioprine]P Van Caneghem, J C Jamoulle, C L Lapière
Pharmaceutical Research|January 1, 1992
Influence of formulation, receptor fluid, and occlusion, on in vitro drug release from topical dosage forms, using an automated flow-through diffusion cellA Rolland, G Demichelis, J C Jamoulle, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal De Pharmacie De Belgique|May 1, 1974
[The synthesis of 3-thiolpyridine 2-sulfonic acid]J C Jamoulle
Annales De Dermatologie Et De Venereologie|January 1, 1988
[Cutaneous penetration]J C Jamoulle
International Journal of Dermatology|July 1, 1988
Skin pharmacokineticsH Schaefer, J C Jamoulle
Journal De Pharmacie De Belgique|March 1, 1975
[Synthesis of some 2-alkylsulfonyl pyridines substituted at the 3-position]J C Jamoulle, C L Lapière
Journal De Pharmacie De Belgique|November 1, 1977
[Synthesis and antimitotic activity of nitro(pyrimidine-2-yl)2-thiopyridines (author's transl)]J C Jamoulle, C L Lapière
Annales Pharmaceutiques Francaises|January 1, 1983
[Anti-ulcerogenic derivatives in the thiocarbonylthiazolidine series: 3-pyridylthiocarbonyl[3,2-d]pyridothiazolidines]J C Jamoulle, C L Lapière
Biochemistry|January 27, 1987
Respective role of each of the purine N7 nitrogens of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine in binding to and activation of the RNase L of mouse cellsJ C Jamoulle, K Lesiak, P F Torrence
Annales Pharmaceutiques Francaises|January 1, 1979
[Synthesis of new potentially antimitotic heterocyclic thioethers (author's transl)]J C Jamoulle, C L Lapiere, J Bourdais
Annales Pharmaceutiques Francaises|January 1, 1985
[Radiosensitizing properties of an analog of azathioprine]P Van Caneghem, J C Jamoulle, C L Lapière
Pharmaceutical Research|January 1, 1992
Influence of formulation, receptor fluid, and occlusion, on in vitro drug release from topical dosage forms, using an automated flow-through diffusion cellA Rolland, G Demichelis, J C Jamoulle, et al.
Pageof 3